Kegg Pathway: Cell adhesion molecules (CAMs)

KEGG ID: 04514

Reference Diagram

KEGG Diagram for Cell adhesion molecules (CAMs)

Rat

There are 145 IPI Records from this pathway found in Rattus norvegicus.

Location of Cell adhesion molecules (CAMs) proteins on Rat Genome

IPI Record Position
1: Alcam 11:49424243-49630071
2: Cd2 2:196332590-196346221
3: Cd226_predicted 18:86083765-86156796
4: Cd22_predicted 1:85924354-85935805
5: Cd276 8:62331015-62361346
6: Cd28 9:59342273-59367743
7: Cd34_predicted 13:110877594-110896736
8: Cd4 4:160988512-161014038
9: Cd40lg X:141925019-141937183
10: Cd6 1:213290835-213329594
11: Cd80 11:64045341-64070083
12: Cd86 11:66215233-66238882
13: Cd8a 4:104589928-104594159
14: Cd8b 4:104536493-104549185
15: Cdh1 19:36442693-36512091
16: Cdh15 19:53182534-53194781
17: Cdh2 18:8048920-8262341
18: Cdh3 19:36343857-36393797
19: Cdh5_predicted 19:779508-1129968
20: Cldn1 11:76473654-76488815
21: Cldn10_predicted 15:103699492-103793404
22: Cldn11 2:116626421-116639732
23: Cldn14 11:34142138-34151928
24: Cldn15_predicted 12:20823572-20844183
25: Cldn16 11:76314467-76333750
26: Cldn17_predicted 11:28370367-28371041
27: Cldn19 5:139838014-139842621
28: Cldn22_predicted 16:47625078-47625740
29: Cldn23 16:60109161-60110885
30: Cldn2_predicted X:127546208-127547889
31: Cldn3 :-
32: Cldn4 12:22816134-22817932
33: Cldn5 :-
34: Cldn6_predicted 10:12945822-12946518
35: Cldn8 11:28421182-28421859
36: Cldn9 10:12947838-12948491
37: Cntn1 7:130658836-130845071
38: Cntn2 13:45399915-45428791
39: Cntnap1 10:90198169-90210837
40: Cspg2 2:19712629-19795039
41: Ctla4 9:59495773-59501300
42: Esam 8:38773224-38784354
43: F11r 13:87369918-87393508
44: Glg1 19:41082324-41176965
45: Glycam1 7:142455642-142457902
46: H2-T18 20:2750921-2758358
47: Hla-dma 20:4844014-4846806
48: Hla-dmb 20:4830090-4836553
49: Icam1 8:20040165-20051949
50: Icam2 10:95772448-95779071
51: Icos :-
52: Igsf4a 8:50765808-51108779
53: Igsf4b_predicted 13:89538603-89574280
54: IPI00362823 3:61919851-62097221
55: IPI00762981 :-
56: Itga6 3:54203293-54272888
57: Itgal 1:186561872-186598114
58: Itgam 1:187334413-187385583
59: Itgav_predicted 3:66952418-67029317
60: Itgb1 19:58601188-58628500
61: Itgb2 20:11446531-11485009
62: Itgb7 7:140971311-140984091
63: Jam2 :-
64: Jam3 8:26697127-26758579
65: L1cam X:159784790-159801553
66: LOC288521 12:16645358-16656498
67: LOC315953 8:104564145-104586332
68: Madcam1 7:11553219-11556621
69: Mag 1:85954511-85970832
70: Mpz 13:87040473-87046199
71: Ncam1 8:52822350-52885664
72: Ncam2 11:20677518-20911422
73: Negr1 2:254666720-255425704
74: Neo1 8:62683127-62794288
75: Nfasc 13:45456189-45551236
76: Nlgn1 2:111189783-111927252
77: Nlgn2 10:56646989-56675100
78: Nlgn3 X:89379028-89398347
79: Nrxn1 6:14731536-14893333
80: Nrxn2 1:209211915-209318066
81: Nrxn3 6:112346042-113904928
82: Pdcd1lg2_predicted 1:233106317-233204167
83: Pdcd1_predicted 9:93173522-93185623
84: Pecam :-
85: Ptprc 13:51247016-51357790
86: Ptprm 9:105785707-106503104
87: PVR 1:79213389-79229052
88: Pvrl1 8:46739494-46798633
89: Pvrl2 1:79021827-79059686
90: Pvrl3_predicted 11:55843791-55940545
91: Q4L2A2_RAT :-
92: RGD1562791_predicted 20:10946782-10950404
93: RGD1564327_predicted 17:86429719-86673201
94: RGD1566211_predicted 1:233053607-233065384
95: RT1-149 20:2812209-2888003
96: RT1-A1 20:5056763-5060280
97: RT1-A2 20:4998645-5025341
98: RT1-A3 :-
99: RT1-Aw2 :-
100: RT1-Ba 20:4697999-4702565
101: RT1-Bb 20:4730559-4737433
102: RT1-CE1 20:3509594-3598018
103: RT1-CE10 20:3468599-3472202
104: RT1-CE11 :-
105: RT1-CE12 :-
106: RT1-CE13 :-
107: RT1-CE14 :-
108: RT1-CE15 :-
109: RT1-CE16 :-
110: RT1-CE2 20:3576838-3579770
111: RT1-CE3 20:3552265-3555613
112: RT1-CE4 20:3536582-3539603
113: RT1-CE5 20:3510167-3513732
114: RT1-CE7 20:3410094-3429824
115: RT1-Cl :-
116: RT1-Da 20:4636344-4641280
117: RT1-Db1 20:4671513-4681365
118: RT1-DOa 20:4890410-4894044
119: RT1-DOb 20:4743651-4759648
120: RT1-Ha 20:4902015-4907717
121: RT1-Ke4 20:4961318-4964651
122: RT1-M1-2 20:1998510-2000712
123: RT1-M1-4 20:1978459-1980679
124: RT1-M10-1 20:2074830-2076950
125: RT1-M2 :-
126: RT1-M6-2 20:1414170-1416692
127: RT1-N1 :-
128: RT1-N3 20:2806577-2810443
129: RT1-O 20:2799232-2801636
130: RT1-S2 20:2794349-2795770
131: RT1-S3 :-
132: RT1-T24-1 20:2907237-2922971
133: RT1.M4_predicted 20:1643837-1647582
134: Sdc1 6:32253352-32275812
135: Sdc2 7:68290768-68406189
136: Sdc3 5:149487938-149518917
137: Sdc4 3:155448002-155464810
138: Sele 13:79813434-79822845
139: Sell 13:79828266-79837503
140: Selp 13:79896091-79922180
141: Selpl_predicted 12:43842268-43843560
142: Siglec1_predicted 3:118770533-118787196
143: Spn 1:186390715-186391887
144: Tnfrsf5 3:156092602-156107432
145: Vcam1 2:212277648-212297394

Mouse

There are 145 IPI Records from this pathway found in Mus musculus.

Location of Cell adhesion molecules (CAMs) proteins on Mouse Genome

IPI Record Position
1: A2AGU5_MOUSE :-
2: A2ANA3_MOUSE X:123188775-123189883
3: Alcam 16:52170261-52373422
4: Cadm1 9:47281368-47601384
5: Cadm3 1:175173422-175204325
6: Cd2 3:101404969-101417000
7: Cd22 7:30574589-30589029
8: Cd226 18:89331620-89404520
9: Cd274 19:29433452-29454094
10: Cd276 9:58322260-58338882
11: Cd28 :-
12: Cd34 1:196639610-196662005
13: Cd4 6:124830325-124853807
14: Cd40 2:164746841-164762859
15: Cd40lg X:53558927-53570826
16: Cd6 19:10856386-10897098
17: Cd80 16:38378357-38405776
18: Cd86 16:36523108-36585290
19: Cd8a 6:71303062-71307116
20: Cd8b1 6:71252366-71263639
21: Cd99 :-
22: Cdh1 8:109492497-109559375
23: Cdh15 8:125734056-125753487
24: Cdh2 :-
25: Cdh3 8:109400042-109446037
26: Cdh4 2:179372030-179825326
27: Cdh5 8:106990828-107033630
28: Cldn1 16:26272000-26287188
29: Cldn10a 14:117701416-117788616
30: Cldn11 3:31340824-31355199
31: Cldn13 5:135199324-135199956
32: Cldn14 16:93807573-93897377
33: Cldn15 5:137252496-137260467
34: Cldn16 16:26378509-26398125
35: Cldn17 16:88395024-88395698
36: Cldn18 9:99500151-99519367
37: Cldn19 4:118753401-118757787
38: Cldn2 X:135147192-135157748
39: Cldn23 8:37293959-37294849
40: Cldn3 5:135270841-135272099
41: Cldn4 5:135230740-135231372
42: Cldn5 16:18690410-18691823
43: Cldn6 17:23406987-23410062
44: Cldn7 11:69781696-69784073
45: Cldn8 16:88451217-88451894
46: Cldn9 17:23410618-23411271
47: Cntn1 15:91956308-92168291
48: Cntn2 1:134336973-134370462
49: Cntnap1 11:100992131-101006814
50: Cntnap2 6:44989897-47228898
51: Ctla4 1:60853571-60860377
52: Esam1 9:37277775-37287983
53: F11r 1:173274236-173301268
54: Glg1 8:114044214-114145875
55: Glycam1 15:103390796-103393112
56: H2-Aa 17:33891095-33896139
57: H2-Bl 17:35688101-35692512
58: H2-D1 :-
59: H2-DMa 17:33746125-33748991
60: H2-DMb1 :-
61: H2-DMb2 17:33756075-33761497
62: H2-Ea 17:33950514-33952226
63: H2-Eb1 17:33913591-33923315
64: H2-K1 17:33606474-33610711
65: H2-M1 17:36278061-36280250
66: H2-M10.1 17:35930911-35934203
67: H2-M10.2 17:35892334-35894474
68: H2-M10.3 17:35973057-35976470
69: H2-M10.4 17:36068217-36070382
70: H2-M10.5 17:36380963-36384290
71: H2-M10.6 17:36420224-36423617
72: H2-M11 17:36155128-36157307
73: H2-M2 17:37088904-37091582
74: H2-M3 17:36878315-36880813
75: H2-M9 17:36248478-36250697
76: H2-Oa 17:33702901-33705273
77: H2-Ob 17:33850627-33862896
78: H2-Q1 17:34987670-34991829
79: H2-Q10 17:35078158-35082606
80: H2-Q2 17:34871167-34953775
81: H2-Q7 17:35047274-35051696
82: H2-Q8 17:35002152-35005858
83: H2-T10 :-
84: H2-T22 17:35646462-35729497
85: H2-T23 17:35638029-35640754
86: H2-T24 17:35614707-35628564
87: H2-T3 17:35793624-35798340
88: H2-T9 :-
89: Icam1 9:20766362-20779199
90: Icam2 11:106193746-106198731
91: Icos 1:60922460-60944866
92: Icosl 10:77474279-77480310
93: Itga4 2:79056339-79133962
94: Itga6 2:71587779-71657597
95: Itga8 2:12024513-12219773
96: Itga9 9:118455407-118747637
97: Itgal 7:127087558-127124876
98: Itgam 7:127853827-127918264
99: Itgav 2:83525354-83604646
100: Itgb1 8:131591503-131618179
101: Itgb2 10:76985685-77009099
102: Itgb2l 16:96527198-96548509
103: Itgb7 15:102044030-102059969
104: Itgb8 12:119612103-119652710
105: Jam2 16:84657025-84707359
106: Jam3 9:26846831-26904839
107: L1cam X:70106675-70133554
108: Madcam1 10:79067712-79071665
109: Mag 7:30607943-30623592
110: Mpz 1:172987388-172997798
111: Mpzl1 1:167441281-167471068
112: Ms10t 17:35032930-35038102
113: Ncam1 9:49257298-49322170
114: Ncam2 16:81083289-81506877
115: Negr1 3:156497488-157248203
116: Neo1 9:58674694-58834562
117: Nfasc 1:134396796-134534872
118: Nlgn1 3:25624711-26324807
119: Nlgn3 X:97476980-97524067
120: Nrcam 12:45199270-45469135
121: Nrxn3 12:89308664-90737434
122: Ocln 13:101597574-101652864
123: OTTMUSG00000018617 19:6428013-6533217
124: Pdcd1 1:95868708-95882959
125: Pdcd1lg2 19:29476955-29537158
126: Pecam1 11:106470307-106566718
127: Ptprc 1:139879826-139991716
128: Ptprf 4:117707733-117775378
129: Ptprm 17:66571893-67259402
130: Pvrl1 9:43495571-43558456
131: Pvrl2 7:18875186-18908047
132: Pvrl3 16:46314342-46416301
133: Q4KN85_MOUSE :-
134: Rmcs5 17:33871432-33877605
135: Sdc1 12:8797404-8819683
136: Sdc2 15:32865312-32979310
137: Sdc3 4:130064613-130098394
138: Sdc4 2:164115452-164134393
139: Sele 1:165884909-165894352
140: Sell 1:165899728-165909011
141: Selp 1:165960377-165985205
142: Selplg 5:114079535-114091474
143: Siglec1 2:130760425-130778206
144: Spn 7:126924612-126928965
145: Vcam1 3:116102024-116121692
146: Vcan 13:90131260-90216522

Human

There are 145 IPI Records from this pathway found in Homo sapiens.

Location of Cell adhesion molecules (CAMs) proteins on Human Genome

IPI Record Position
1: ALCAM 3:106568403-106778433
2: CADM1 11:114552404-114880322
3: CADM3 :-
4: CD2 1:117098530-117113373
5: CD22 19:40511944-40530098
6: CD226 18:65681175-65775140
7: CD274 9:5440525-5460547
8: CD276 15:71763675-71793903
9: CD28 2:204279443-204310801
10: CD34 1:206116942-206151370
11: CD4 12:6769005-6800233
12: CD40 20:44180318-44366257
13: CD40LG X:135558002-135570215
14: CD58 1:116858680-116915184
15: CD6 11:60495728-60544422
16: CD80 3:120725835-120761139
17: CD86 3:123256911-123322672
18: CD8A 2:86865245-86871578
19: CD8B 2:86895973-86942549
20: CD99 X:2619220-2669350
21: CDH1 16:67328696-67426943
22: CDH15 16:87765664-87789400
23: CDH2 18:23784934-24011189
24: CDH3 16:67236240-67290440
25: CDH4 20:59260954-59945672
26: CDH5 16:64958064-64996186
27: CLDN1 3:191506197-191522909
28: CLDN10 13:94883859-95030014
29: CLDN11 3:171619359-171634577
30: CLDN14 21:36754793-36870737
31: CLDN16 3:191588535-191611027
32: CLDN17 21:30460132-30460806
33: CLDN18 3:139200348-139235184
34: CLDN19 1:42971351-42978512
35: CLDN2 X:106030050-106060747
36: CLDN20 6:155626839-155639374
37: CLDN22 4:184477703-184478365
38: CLDN23 8:8597319-8598197
39: CLDN3 7:72821653-72822315
40: CLDN4 7:72880010-72884950
41: CLDN5 22:17890550-17895068
42: CLDN6 16:3004715-3008187
43: CLDN7 17:7103390-7107236
44: CLDN8 21:30508196-30510223
45: CLDN9 16:3002458-3004507
46: CNTN1 12:39508281-39750361
47: CNTN2 1:203278963-203313759
48: CNTNAP1 17:38088158-38105358
49: CNTNAP2 7:145444902-147749019
50: CTLA4 2:204440756-204446928
51: ESAM 11:124128240-124137396
52: F11R 1:159231625-159275404
53: GLG1 16:73043357-73198518
54: HLA-DMA 6:32987979-32992453
55: HLA-DMB 6:32973998-32980399
56: HLA-DOA 6:33043508-33048938
57: HLA-DOB 6:32888518-32892803
58: HLA-DPA1 6:33104701-33113285
59: HLA-DPB1 6:33151694-33162956
60: HLA-DQA1 6:32713112-32719345
61: HLA-DQA2 6:32817141-32823171
62: HLA-DQB1 6:32698557-32705974
63: HLA-DQB2 6:32831445-32839446
64: HLA-DRA 6:32507971-32513151
65: HLA-E 6:30565198-30569950
66: HLA-F 6:29832424-29836307
67: HLA-G 6:30111128-30114493
68: ICAM1 19:10242765-10258291
69: ICAM2 17:59433708-59451710
70: ICAM3 19:10305454-10311337
71: ICOS 2:204509716-204534541
72: ICOSLG 21:44467313-44485151
73: ITGA4 2:182029864-182110711
74: ITGA6 2:173000616-173079256
75: ITGA8 10:15595954-15802130
76: ITGA9 3:37468817-37836285
77: ITGAL 16:30391551-30441772
78: ITGAM 16:31180512-31251207
79: ITGAV 2:187163045-187253872
80: ITGB1 10:33229326-33287204
81: ITGB2 21:45130334-45173181
82: ITGB7 12:51871375-51887267
83: ITGB8 7:20337271-20416944
84: JAM2 21:25933515-26009078
85: JAM3 11:133444030-133526846
86: L1CAM X:152780163-152804802
87: MADCAM1 19:447490-456342
88: MAG 19:40474877-40496547
89: MPZ 1:159541149-159546368
90: MPZL1 1:165957832-166026682
91: NCAM1 11:112578307-112653781
92: NCAM2 21:21574767-21834285
93: NEGR1 1:71641213-72521005
94: NEO1 15:71131928-71384592
95: NLGN1 3:174805083-175481787
96: NLGN2 17:7252226-7263903
97: NLGN3 X:70281418-70307776
98: NRCAM 7:107575318-107884062
99: NRXN1 2:50000992-50428370
100: NRXN2 11:64130222-64247236
101: NRXN3 14:77779190-79400511
102: OCLN 5:68823875-68885887
103: PDCD1 2:242440711-242449731
104: PDCD1LG2 9:5500570-5561252
105: PECAM1 17:59754404-59794504
106: PTPRC 1:196874424-196993035
107: PTPRF 1:43769134-43861924
108: PTPRM 18:7557817-8396160
109: PVR 19:49839066-49858689
110: PVRL1 11:119014018-119104645
111: PVRL2 19:50041390-50083476
112: PVRL3 3:112273555-112395063
113: SDC1 2:20264039-20288675
114: SDC2 8:97575058-97693213
115: SDC3 1:31114901-31154195
116: SDC4 20:43387342-43410478
117: SELE 1:167958406-167969827
118: SELL 1:167926432-167947463
119: SELP 1:167824661-167866023
120: SELPLG 12:107540974-107542212
121: SIGLEC1 20:3615619-3635775
122: SPN 16:29582077-29589688
123: VCAM1 1:100957885-100977185
124: VCAN 5:82803339-82912737

Google Scholar

Recent Literature

PU/PTFE-stimulated monocyte-derived soluble factors induced inflammatory activation in endothelial Cells.

Toxicol In Vitro. 2009 Nov 4;
Xue Y, Liu X, Sun J

Polyurethane (PU) and polytetrafluoroethylene (PTFE) are two commonly used blood-contacting biomaterials. In the present study, we used a noncontact coculture model to evaluate the thrombosis-causing potential of monocyte-mediated PU and PTFE. We used human endothelial Cells from umbilical cord (HUVECs) and human monocytes (THP1 Cells). The THP1 Cells were directly exposed to PU/PTFE, and the resultant Cell-free supernatants were harvested for stimulating HUVECs. The treated HUVECs constituted the test group. HUVECs treated with supernatants of LPS-stimulated THP1 Cells were used as the positive controls. To investigate the effects of the supernatant treatment on HUVECs, we measured the expression of the leukocyte-endothelial-Cell adhesion molecules (CAMs) CD54 (ICAM-1), CD106 (VCAM-1), and CD62E (E-selectin) and evaluated the release of tissue factor (TF). The results demonstrated that both PU and PTFE induced the expressions of CD62E and TF. These activation effects were accompanied by activation of the NF-kappaB transcription factor. To further investigate the monocyte-derived soluble factors that might contribute to these effects, we evaluated the effects of the PU/PTFE stimulation on the expression of reactive oxygen species (ROS), TNF-alpha, IL-1beta, and IL-6 in monocyte monocultures. In comparison with the results for the negative control, both PU and PTFE significantly induced ROS release after 0.5h, while the expressions of TNF-alpha, IL-1beta, and IL-6 were variably increased after 24h. Our results suggest that the biomaterial induces monocytic activation and subsequently causes the release of soluble factors, which contribute to the inflammatory activation in HUVECs.

Acteoside and 6-O-acetylacteoside downregulate Cell adhesion molecules induced by IL-1beta through inhibition of ERK and JNK in human vascular endothelial Cells.

J Agric Food Chem. 2009 Oct 14; 57(19): 8852-9
Chen CH, Song TY, Liang YC, Hu ML

Acteoside, an active phenylethanoid glycoside of many medicinal plants and bitter tea, displays anti-inflammatory properties in vitro. However, it is unclear whether acteoside and similar compounds may inhibit the expression of Cell adhesion molecules (CAMs), which plays a role in the pathogenesis of atherosclerosis and inflammation. Here, we found that acteoside, isoacteoside, and 6-O-acetylacteoside inhibited IL-1beta-activated expression of interCellular CAM-1 (ICAM-1) and vascular CAM-1 (VCAM-1) in human umbilical vein endothelial Cells (HUVECs); the inhibitory potency was as follows: 6-O-acetylacteoside > acteoside > isoacteoside. Acteoside and 6-O-acetylacteoside also dose-dependently inhibited VCAM-1 gene promoter activity in IL-1beta-activated HUVECs. The inhibition of acteoside and 6-O-acetylacteoside on IL-1beta-activated expression of CAMs was manifested by decreased phosphorylation of extraCellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK). These results indicate that acteoside and 6-O-acetylacteoside may exert anti-inflammatory activities in vascular endothelium by inhibiting the expression of CAMs, primarily through decreased phosphorylation of ERK and JNK.

Effects of Shikonin isolated from Zicao on lupus nephritis in NZB/W F1 mice.

Biol Pharm Bull. 2009 Sep; 32(9): 1565-70
Wang XC, Feng J, Huang F, Fan YS, Wang YY, Cao LY, Wen CP

The present study was performed to evaluate the potential protective effects of Shikonin extracted from Zicao on lupus nephritis (LN) using NZB/W F1 mice. Oral administration of Shikonin (24, 40 mg/kg body weight/d) or vehicle was applied to sixty female NZB/W F1 mice of 28-week-old with LN. Treatment with Shikonin for 14 weeks suppressed proteinuria dose-dependently with the mean proteinuria of 274.0 mg/dl and 160.3 mg/dl for low-dose and high-dose Shikonin groups, respectively, compared to 499.2 mg/dl for the vehicle. Also, Shikonin was observed to reduce circulating adhesion molecules significantly and down-regulate interCellular adhesion molecule-1 (ICAM-1) and vascular Cell adhesion molecule-1 (VCAM-1) mRNA expression in kidney. However, anti-double stranded (ds)DNA antibody in mice with low or high Shikonin dose administration both exhibited no significant elevation, differing from vehicle group. Kidney histological examination showed that renal glomerular lesions were alleviated after Shikonin application. These results suggest that Shikonin has therapeutic effects on LN in NZB/W F1 mice, to which inhibition of anti-dsDNA may be potential contribution, and its part mechanism is related to suppression of mRNA expression of Cell adhesion molecules (CAMs) in the kidney.

IgLON Cell adhesion molecules regulate synaptogenesis in hippocampal neurons.

Cell Biochem Funct. 2009 Oct; 27(7): 496-8
Hashimoto T, Maekawa S, Miyata S

IgLON Cell adhesion molecules (CAMs) belonging to the immunoglobulin superfamily comprise of LAMP, neurotrimin (Ntm), OBCAM, and Kilon. In the present study, we performed the single and double transfection of IgLON gene constructs into hippocampal neurons in vitro and evaluated synaptic number. The quantitative analysis showed that the single over-expression of LAMP or OBCAM increased synaptic number, while the over-expression of Kilon reduced synaptic number and Ntm had no effects. The double over-expression of Kilon-Ntm, Kilon-OBCAM, LAMP-Ntm, and Ntm-OBCAM decreased synaptic number and that of Kilon-LAMP and LAMP-OBCAM had no effect. These results suggest that IgLON CAMs participate in regulating synapse formation in hippocampal neurons.

Modulation of synaptic transmission and plasticity by Cell adhesion and repulsion molecules.

Neuron Glia Biol. 2008 Aug; 4(3): 197-209
Dityatev A, Bukalo O, Schachner M

Adhesive and repellent molecular cues guide migrating Cells and growing neurites during development. They also contribute to synaptic function, learning and memory in adulthood. Here, we review the roles of Cell adhesion molecules of the immunoglobulin superfamily (Ig-CAMs) and semaphorins (some of which also contain Ig-like domains) in regulation of synaptic transmission and plasticity. Interestingly, among the seven studied Ig-CAMs, the neuronal Cell adhesion molecule proved to be important for all tested forms of hippocampal plasticity, while its associated unusual glycan polysialic acid is necessary and sufficient part for synaptic plasticity only at CA3-CA1 synapses. In contrast, Thy-1 and L1 specifically regulate long-term potentiation (LTP) at synapses formed by entorhinal axons in the dentate gyrus and cornu ammonis, respectively. Contactin-1 is important for long-term depression but not for LTP at CA3-CA1 synapses. Analysis of CHL1-deficient mice illustrates that at intermediate stages of development a deficit in a Cell adhesion molecule is compensated but appears as impaired LTP during early and late postnatal development. The emerging mechanisms by which adhesive Ig-CAMs contribute to synaptic plasticity involve regulation of activities of NMDA receptors and L-type Ca2+ channels, signaling via mitogen-activated protein kinase p38, changes in GABAergic inhibition and motility of synaptic elements. Regarding repellent molecules, available data for semaphorins demonstrate their activity-dependent regulation in normal and pathological conditions, synaptic localization of their receptors and their potential to elevate or inhibit synaptic transmission either directly or indirectly.

Role of inflammation (leukocyte-endothelial Cell interactions) in vasospasm after subarachnoid hemorrhage.

Surg Neurol. 2009 Aug 5;
Chaichana KL, Pradilla G, Huang J, Tamargo RJ

BACKGROUND: Delayed vasospasm is the leading cause of morbidity and mortality after aneurysmal subarachnoid hemorrhage (aSAH). This phenomenon was first described more than 50 years ago, but only recently has the role of inflammation in this condition become better understood. METHODS: The literature was reviewed for studies on delayed vasospasm and inflammation. RESULTS: There is increasing evidence that inflammation and, more specifically, leukocyte-endothelial Cell interactions play a critical role in the pathogenesis of vasospasm after aSAH, as well as in other conditions including meningitis and traumatic brain injury. Although earlier clinical observations and indirect experimental evidence suggested an association between inflammation and chronic vasospasm, recently direct molecular evidence demonstrates the central role of leukocyte-endothelial Cell interactions in the development of chronic vasospasm. This evidence shows in both clinical and experimental studies that Cell adhesion molecules (CAMs) are up-regulated in the perivasospasm period. Moreover, the use of monoclonal antibodies against these CAMs, as well as drugs that decrease the expression of CAMs, decreases vasospasm in experimental studies. It also appears that certain individuals are genetically predisposed to a severe inflammatory response after aSAH based on their haptoglobin genotype, which in turn predisposes them to develop clinically symptomatic vasospasm. CONCLUSION: Based on this evidence, leukocyte-endothelial Cell interactions appear to be the root cause of chronic vasospasm. This hypothesis predicts many surprising features of vasospasm and explains apparently unrelated phenomena observed in aSAH patients. Therapies aimed at preventing inflammation may prevent and/or reverse arterial narrowing in patients with aSAH and result in improved outcomes.

Effect of caffeic acid on tumor necrosis factor-alpha-induced vascular inflammation in human umbilical vein endothelial Cells.

Biol Pharm Bull. 2009 Aug; 32(8): 1371-7
Moon MK, Lee YJ, Kim JS, Kang DG, Lee HS

Recruitment of specific leukocyte subpopulations at the site of inflammation requires a series of Cell adhesion molecules (CAMs)-mediated interactions. The major CAMs, viz., intraCellular adhesion molecule-1 (ICAM-1), vascular Cell adhesion molecule-1 (VCAM-1), and E-selectin are expressed on endothelium in response to various cytokines. Caffeic acid (CA), a natural phenolic compound from herbs and other sources, has been shown to prevent cardiovascular diseases. We investigated the effect of CA on the expression of CAMs by human umbilical vein endothelial Cells (HUVECs) stimulated with tumor necrosis factor (TNF-alpha). adhesion of monocytes to CA-treated HUVECs was evaluated by co-culture experiments using 2,7-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethylester (BCECF-AM) labeling of U937 Cells. The expression of adhesion and chemoattractant molecules was evaluated by Western blot and reverse transcription-polymerase chain reaction (RT-PCR), respectively. CA significantly inhibited the TNF-alpha-induced increase in U937 monocyte adhesion to HUVECs as well as decreased the protein and mRNA expression levels of CAMs on HUVECs. CA also inhibited the mRNA expression of monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8). The involvement of nuclear factor (NF)-kappaB in the transcriptional control of CAMs protein was assessed by degradation of inhibitory (I)kappaB and nuclear translocation of NF-kappaB using Western blotting and immunofluorescence staining. CA attenuated TNF-alpha-induced IkappaB degradation and NF-kappaB translocation from cytosol to the nucleus. In conclusion, TNF-alpha-induced NF-kappaB-DNA complex formation was inhibited by CA. CA reduced TNF-alpha-induced endothelial adhesiveness to HUVECs by inhibiting transcription factor activation, and CAMs expression suggesting its potential role in atherosclerosis diseases.

NADPH oxidase and lipid raft-associated redox signaling are required for PCB153-induced upregulation of Cell adhesion molecules in human brain endothelial Cells.

Toxicol Appl Pharmacol. 2009 Oct 15; 240(2): 299-305
Eum SY, Andras I, Hennig B, Toborek M

Exposure to persistent organic pollutants, such as polychlorinated biphenyls (PCBs), can lead to chronic inflammation and the development of vascular diseases. Because Cell adhesion molecules (CAMs) of the cerebrovascular endothelium regulate infiltration of inflammatory Cells into the brain, we have explored the molecular mechanisms by which ortho-substituted polychlorinated biphenyls (PCBs), such as PCB153, can upregulate CAMs in brain endothelial Cells. Exposure to PCB153 increased expression of interCellular adhesion molecule-1 (ICAM-1) and vascular Cell adhesion molecule-1 (VCAM-1), as well as elevated adhesion of leukocytes to brain endothelial Cells. These effects were impeded by inhibitors of EGFR, JAKs, or Src activity. In addition, pharmacological inhibition of NADPH oxidase or disruption of lipid rafts by cholesterol depleting agents blocked PCB153-induced phosphorylation of JAK and Src kinases and upregulation of CAMs. In contrast, silencing of caveolin-1 by siRNA interference did not affect upregulation of ICAM-1 and VCAM-1 in brain endothelial Cells stimulated by PCB153. Results of the present study indicate that lipid raft-dependent NADPH oxidase/JAK/EGFR signaling mechanisms regulate the expression of CAMs in brain endothelial Cells and adhesion of leukocytes to endothelial monolayers. Due to its role in leukocyte infiltration, induction of CAMs may contribute to PCB-induced cerebrovascular disorders and neurotoxic effects in the CNS.

Pathogenic human L1-CAM mutations reduce the adhesion-dependent activation of EGFR.

Hum Mol Genet. 2009 Oct 15; 18(20): 3822-31
Nagaraj K, Kristiansen LV, Skrzynski A, Castiella C, Garcia-Alonso L, Hortsch M

L1-Cell adhesion molecule (L1-CAM) belongs to a functionally conserved group of neural Cell adhesion molecules that are implicated in many aspects of nervous system development. In many neuronal Cells the adhesive function of L1-type CAMs induces Cellular signaling processes that involves the activation of neuronal tyrosine protein kinases and among other functions regulates axonal growth and guidance. Mutations in the human L1-CAM gene are responsible for a complex neurodevelopmental condition, generally referred to as L1 syndrome. Several pathogenic L1-CAM mutations have been identified in humans that cause L1 syndrome in affected individuals without affecting the level of L1-CAM-mediated homophilic Cell adhesion when tested in vitro. In this study, an analysis of two different pathogenic human L1-CAM molecules indicates that although both induce normal L1-CAM-mediated Cell aggregation, they are defective in stimulating human epidermal growth factor receptor tyrosine kinase activity in vitro and are unable to rescue L1 loss-of-function conditions in a Drosophila transgenic model in vivo. These results indicate that the L1 syndrome-associated phenotype might involve the disruption of L1-CAM's functions at different levels. Either by reducing or abolishing L1-CAM protein expression, by interfering with L1-CAM's Cell surface expression, by reducing L1-CAM's adhesive ability or by impeding further downstream adhesion-dependent signaling processes.

A distinct profile of serum levels of soluble interCellular adhesion molecule-1 and interCellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.

J Am Acad Dermatol. 2009 Aug; 61(2): 263-70
López-Lerma I, Estrach MT

BACKGROUND: Cell adhesion molecules (CAMs) play a pivotal role in cutaneous localization of T Cells. Tissue-selective localization of T lymphocytes to the skin is crucial for immune surveillance and in the pathogenesis of skin disorders. OBJECTIVE: To detect the profile of soluble CAMs in patients with cutaneous T-Cell lymphoma (CTCL), we investigated the levels of interCellular adhesion molecule-1 (ICAM-1, soluble ICAM-1 [sICAM-1]); interCellular adhesion molecule-3 (sICAM-3); vascular Cell adhesion molecule-1 (sVCAM-1); and E-selectin (sE-selectin) in sera from patients with T-Cell-mediated skin diseases. METHODS: Serum levels of the 4 CAMs were measured by enzyme-linked immunosorbent assay in 42 participants including 11 patients with early stages of CTCL; 7 with advanced stages of CTCL including Sézary syndrome; 12 with inflammatory skin diseases (psoriasis and atopic dermatitis); 8 with skin diseases that may evolve into CTCL; and healthy individuals. Levels were correlated with biological parameters known as prognostic factors in non-Hodgkin lymphomas. RESULTS: In patients with CTCL, significantly increased levels of sICAM-1 and sICAM-3 were found when compared with healthy individuals and patients with inflammatory dermatosis. Soluble E-selectin and sVCAM-1 levels were not increased. There were significant positive correlations between sICAM-1 and sICAM-3 levels and each of them with beta2-microglobulin levels. LIMITATIONS: Limited number of patients was a limitation. CONCLUSION: There is a distinct profile of soluble CAMs in patients with CTCL. However, future studies with a larger group of patients are needed to confirm these findings. We propose that high sICAM-1 and sICAM-3 levels have important implications in the context of immune response and immune surveillance in these patients.

The voltage-gated Na+ channel beta3 subunit does not mediate trans homophilic Cell adhesion or associate with the Cell adhesion molecule contactin.

Neurosci Lett. 2009 Oct 25; 462(3): 272-5
McEwen DP, Chen C, Meadows LS, Lopez-Santiago L, Isom LL

Voltage-gated Na(+) channel (VGSC) beta1 and beta2 subunits are multifunctional, serving as both channel modulators and Cell adhesion molecules (CAMs). The purpose of this study was to determine whether VGSC beta3 subunits function as CAMs. The beta3 extraCellular domain is highly homologous to beta1, suggesting that beta3 may also be a functional CAM. We investigated the trans homophilic Cell adhesive properties of beta3, its association with the beta1-interacting CAM contactin, as well as its ability to interact with the cytoskeletal protein ankyrin. Our results demonstrate that, unlike beta1, beta3 does not participate in trans homophilic Cell-Cell adhesion or associate with contactin. Further, beta3 does not associate with ankyrin(G) in a heterologous system. Previous studies have shown that beta3 interacts with the CAM neurofascin-186 but not with VGSC beta1. Taken together, these findings suggest that, although beta1 and beta3 exhibit similar channel modulatory properties in heterologous systems, these subunits differ with regard to their homophilic and heterophilic CAM binding profiles.

Cell-Cell adhesion in the prelaminar region of the optic nerve head: a possible target for ionic stress.

Ophthalmic Res. 2009; 42(2): 106-11
Carreras FJ, Porcel D, Alaminos M, Garzón I

PURPOSE: This paper aims to study the anterior surface of the optic nerve in relation to its ability to support a source of stress acting from the vitreous cavity. The interCellular junctions of the lining astrocytes mediated by Cellular adhesion molecules (CAMs) may be the main targets for ionic stress. METHODS: The optic nerve of the domestic pig was prepared for light, confocal laser and transmission electron microscopy. Immunostaining was performed for antibodies against glial fibrillary acidic protein, neural cadherin (N-cadherin) and neural CAM (N-CAM). RESULTS: Only 1 type of interCellular junction was found among the bordering astrocytes, which was characterized as a zonula adherens. Unions between lining Cells showed a positive immunogold effect and immunofluorescence against N-cadherin in the zonula adherens and membrane apposition. N-CAM was also present in areas of nonjunctional Cellular adhesion. CONCLUSION: The stability of interCellular junctions of the nerve-vitreous boundary is sensitive to altered concentrations of Ca(2+). Since aqueous humor has half the Ca(2+) concentration of plasma, any contact of aqueous humor with the optic nerve head can interfere with the ionic concentration of calcium in the extraCellular spaces. This mechanism may contribute to age-related changes and some types of glaucoma.

Vascular Cell adhesion molecule-1 expression in human intestinal microvascular endothelial Cells is regulated by PI 3-kinase/Akt/MAPK/NF-kappaB: inhibitory role of curcumin.

Am J Physiol Gastrointest Liver Physiol. 2009 Aug; 297(2): G259-68
Binion DG, Heidemann J, Li MS, Nelson VM, Otterson MF, Rafiee P

Endothelial activation and surface expression of Cell adhesion molecules (CAMs) is critical for binding and recruitment of circulating leukocytes in tissues during the inflammatory response. Endothelial CAM expression plays a critical role in the intestinal microvasculature in inflammatory bowel disease (IBD), as blockade of leukocyte alpha4-integrin binding by gut endothelial CAM ligands has therapeutic benefit in IBD. Mechanisms underlying expression of vascular Cell adhesion molecule (VCAM)-1, a ligand for alpha4-integrin in primary cultures of human intestinal microvascular endothelial Cells (HIMEC) has not been defined. We investigated the effect of curcumin, phosphatidylinositol 3-kinase (PI 3-kinase)/protein kinase B (Akt), and mitogen-activated protein kinase (MAPK) inhibitors on VCAM-1 expression and function in HIMEC. CAM expression was assessed and HIMEC-leukocyte adhesion was visualized under static and flow conditions. Western blotting and in vitro kinase assays were used to assess Akt and MAPK activation. Nuclear factor-kappaB (NF-kappaB) activation and nuclear translocation of its p65 subunit were determined. Tumor necrosis factor (TNF)-alpha/lipopolysaccharide (LPS)-induced VCAM-1 expression in HIMEC was suppressed by Akt small-interfering RNA, curcumin, and inhibitors of NF-kappaB (SN-50), p38 MAPK (SB-203580) and PI 3-kinase/Akt (LY-294002). VCAM-1 induction was partially suppressed by p44/42 MAPK (PD-098059) but unaffected by c-Jun NH2-terminal kinase (SP-600125) inhibition. Curcumin inhibited Akt/MAPK/NF-kappaB activity and prevented nuclear translocation of the p65 NF-kappaB subunit following TNF-alpha/LPS. At physiological shear stress, curcumin attenuated leukocyte adhesion to TNF-alpha/LPS-activated HIMEC monolayers. In conclusion, curcumin inhibited the expression of VCAM-1 in HIMECs through blockade of Akt, p38 MAPK, and NF-kappaB. Curcumin may represent a novel therapeutic agent targeting endothelial activation in IBD.

Cytokine regulation during the formation of the fetal-maternal interface: focus on Cell-Cell adhesion and remodelling of the extra-Cellular matrix.

Cytokine Growth Factor Rev. 2009 Jun; 20(3): 241-9
McEwan M, Lins RJ, Munro SK, Vincent ZL, Ponnampalam AP, Mitchell MD

The establishment of human pregnancy requires the orchestration of substantial Cell differentiation and tissue remodelling processes in the context of a complex dialogue between the receptive endometrium and the implanting blastocyst, and is therefore dependent upon a complex sequence of signalling events. Cytokines play an important role in each step of implantation, modulating expression of adhesion molecules on both the fetal and maternal surfaces, regulating expression of the proteases that remodel the extra-Cellular matrix, and promoting invasion and differentiation of trophoblasts. Here we review the role of cytokines in regulating the establishment of the fetal-maternal interface, with a particular focus on regulation of the functional expression of CAMs, the ECM and of the proteinases that modulate their function.

L1 Cell adhesion molecules as regulators of tumor Cell invasiveness.

Cell Adh Migr. 2009 Jul-Sep; 3(3): 275-7
Siesser PF, Maness PF

Fast growing malignant cancers represent a major therapeutic challenge. Basic cancer research has concentrated efforts to determine the mechanisms underlying cancer initiation and progression and reveal candidate targets for future therapeutic treatment of cancer patients. With known roles in fundamental processes required for proper development and function of the nervous system, L1-CAMs have been recently identified as key players in cancer biology. In particular L1 has been implicated in cancer invasiveness and metastasis, and has been pursued as a powerful prognostic factor, indicating poor outcome for patients. Interestingly, L1 has been shown to be important for the survival of cancer stem Cells, which are thought to be the source of cancer recurrence. The newly recognized roles for L1CAMs in cancer prompt a search for alternative therapeutic approaches. Despite the promising advances in cancer basic research, a better understanding of the molecular mechanisms dictating L1-mediated signaling is needed for the development of effective therapeutic treatment for cancer patients.

The functional role of Cell adhesion molecules in tumor angiogenesis.

Semin Cancer Biol. 2009 May 29;
Francavilla C, Maddaluno L, Cavallaro U

Cell adhesion molecules (CAMs) are Cell surface glycoproteins that mediate the physical interactions between adjacent Cells and between Cells and the surrounding extraCellular matrix. CAMs belong to different protein families, depending on their structural and functional properties. Furthermore, the expression of certain CAMs under physiological conditions is restricted to specific Cell types. Besides playing a key homeostatic role in maintaining the architecture of quiescent tissues, CAMs have also to adapt to the microenvironmental changes that occur during certain physiological and pathological processes. This is best exemplified by cancer vascularization, where the expression and function of vascular CAMs are dynamically regulated in response to tissue alterations induced by tumor growth as well as by changes in the surrounding stroma. This enables endothelial Cells (ECs) to leave the quiescent state and re-enter the angiogenic cascade. The latter is a multistep process carried out by different types of specialized ECs. This review describes the actual or supposed function of the various CAM subsets in the sequential series of events that underlie vascular changes during tumor angiogenesis. Notably, elucidating the mechanism of action of endothelial CAMs in cancer vasculature is expected to open new therapeutic avenues aimed at interfering with tumor growth and dissemination.

Controlled deposition of Cells in sealed microfluidics using flow velocity boundaries.

Lab Chip. 2009 May 21; 9(10): 1395-402
Lovchik RD, Bianco F, Matteoli M, Delamarche E

We present a method for depositing Cells in a sealed microfluidic device. The device consists of a poly(dimethylsiloxane) (PDMS) microfluidic network (MFN) sealed with a Si chip. The Si chip has vias and ports that are connected to high-precision motorized pumps. The surfaces of the PDMS MFN are homogeneously coated with fibronectin Cell adhesion molecules (CAMs). Flow velocity boundaries are created between vicinal microfluidic structures to prevent or permit deposition of Cells in specific regions of the MFN. In narrow flow paths, Cells experience a wall shear stress from the fast-moving liquid that overcomes the initial adhesion of the Cells with CAMs. Conversely, Cells can adhere to CAMs in larger flow paths such as Cell chambers inside which the velocity of the liquid and the shear stress are reduced. Interactively changing pumping rates makes the critical velocity (the velocity at which Cells deposit in the chamber but not elsewhere) easy to find. The transparent PDMS MFN allows both real-time visualization of the deposition process and Cellular assays. We illustrate this method using N9 mouse microglia Cells. In one experiment, approximately 75 microglia are deposited per min in a approximately 0.5 microL chamber. The deposited Cells remain viable, as assessed from staining and biofunctional assays. This method is simple, reliable, fast, and flexible, and therefore is an attractive technique for depositing Cells in microfluidic systems for numerous applications.

Non-conventional markers of atherosclerosis before and after gastric banding surgery.

Eur Heart J. 2009 Jun; 30(12): 1516-24
Hanusch-Enserer U, Zorn G, Wojta J, Kopp CW, Prager R, Koenig W, Schillinger M, Roden M, Huber K

AIMS: Obesity and type 2 diabetes are associated with increased cardiovascular risk and elevation of traditional and non-traditional risk markers. As bariatric surgery reduces overweight and improves metabolic derangement, we examined a cluster of established and emerging cardiovascular risk factors, such as soluble CD40 ligand (sCD40L) and lipoprotein-associated phospholipase A(2) (Lp-PLA(2)), which might improve prediction of future cardiovascular events because of their more direct involvement in plaque destabilization. METHODS AND RESULTS: Obese patients [n = 32, body mass index (BMI) 46.1 +/- 5.9 kg/m(2)] underwent clinical examinations and blood sampling for measurement of glucose and lipid parameters as well as non-traditional cardiovascular risk markers, i.e. high-sensitivity C-reactive protein, plasminogen activator inhibitor-1 (PAI-1), soluble Cellular adhesion molecules (CAM), MMP-2, MMP-9, CD40L, and Lp-PLA(2) before and after 1 year following laparoscopic adjustable gastric banding (LAGB), respectively. In patients undergoing LAGB, blood pressure (P < 0.0001) and blood glucose (P = 0.02) were significantly lowered by approximately 16% as well as triglyceride levels by approximately 29% (P = 0.002). In addition to a decrease of the inflammatory and pro-thrombotic marker PAI-1 (P = 0.001), CAMs, and MMP-9 (P = 0.004) were reduced, whereas no change was observed for plasma levels of MMP-2, sCD40L, and Lp-PLA(2) after LAGB, respectively. Individual changes in (ICAM-1) interCellular adhesion molecule-1 (DeltaICAM-1) were related to changes in insulin (Deltafasting insulin) before and after LAGB (r = 0.36 and r = 0.38; both P = 0.04). E-selectin correlated positively with changes in BMI (r = 0.38; P = 0.04 and r = 0.36; P = 0.05), while Lp-PLA(2) concentration was negatively correlated with BMI (r =-0.41; P = 0.02) after 1 year. Changes were comparable in both overweight diabetic and non-diabetic subjects. CONCLUSION: LAGB not only induced weight loss but also an improvement in the subclinical pro-inflammatory state. However, concentrations of most of the non-traditional risk factors for plaque instability, i.e. MMP-9, sCD40L, and Lp-PLA(2) remained unchanged.

The intraCellular interactions of the L1 family of Cell adhesion molecules.

Biochem J. 2009 May 1; 419(3): 519-31
Herron LR, Hill M, Davey F, Gunn-Moore FJ

The L1 family of CAMs (Cell adhesion molecules) has long aroused the interest of researchers, but primarily the extraCellular interactions of these proteins have been elucidated. More recently, attention has turned to the intraCellular signalling potentiated by transmembrane proteins and the cytoplasmic proteins with which they can interact. The present review brings up to date the current body of published knowledge for the intraCellular interactions of L1-CAM family proteins and the potential importance of these interactions for the mechanisms of L1-CAM action.

Blockade of ICAM-1: a novel way of vasculitis treatment.

Biochem Biophys Res Commun. 2009 Apr 17; 381(4): 459-61
Xu Y, Li S

Vasculitis is becoming more common worldwide, but there is no effective therapeutic method towards this series of disease till now. InterCellular adhesion molecule (ICAM)-1 is one of an important Cell adhesion molecules (CAMs) family glycoprotein that plays pivotal role in inflammation process and participates in vasculitis. Blockade of ICAM-1 has been witnessed with its satisfactory effect on inflammatory disease treatment. Therefore, this method may be considered as a novel way towards treatment of vasculitis.